SHARE

Sanofi appoints CEO amid innovation challenges

Sanofi has named Belén Garijo as Chief Executive, succeeding Paul Hudson, following struggles in new drug development. Belén, who is currently CEO of Merck KGaA, will assume her role after Sanofi’s AGM on April 29.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.